Cancer Research Landon Prizes for Basic and Translational Cancer Research  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Whiteside, D.
Right arrow Articles by Andrew, S. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Whiteside, D.
Right arrow Articles by Andrew, S. E.
[Cancer Research 62, 359-362, January 15, 2002]
© 2002 American Association for Cancer Research


Advances in Brief

A Homozygous Germ-Line Mutation in the Human MSH2 Gene Predisposes to Hematological Malignancy and Multiple Café-au-Lait Spots1

Darcy Whiteside, Ross McLeod, Gail Graham, Jamie L. Steckley, Karen Booth, Martin J. Somerville and Susan E. Andrew2

Department of Medical Genetics, University of Alberta, Edmonton, Alberta, T6G 2H7 Canada [D. W., J. L. S., M. J. S., S. E. A.], and Department of Medical Genetics, Alberta Children’s Hospital, Calgary, Alberta, T2T 5C7 Canada [R. M., G. G., K. B.]

Individuals with a germ-line mutation in one of the DNA mismatch repair (MMR) genes are at significant risk for colorectal cancer and other tumors. Three families have previously been reported with individuals homozygous for mutations in the MMR gene MLH1 that are predicted to compromise MMR. These individuals develop hematological malignancies and/or neurofibromatosis type 1 at an early age. Here, in an individual, we demonstrate that a homozygous novel mutation in the MMR gene MSH2 is associated with leukemia and multiple café-au-lait spots, a feature of neurofibromatosis type 1. Because the hematological malignancies observed in the individuals homozygous for the loss of MMR are reflective of the lymphomas seen in mice lacking MMR, the mice may provide a useful model for human neoplasia.




This article has been cited by other articles:


Home page
Cancer Res.Home page
H. Feitsma, R. V. Kuiper, J. Korving, I. J. Nijman, and E. Cuppen
Zebrafish with Mutations in Mismatch Repair Genes Develop Neurofibromas and Other Tumors
Cancer Res., July 1, 2008; 68(13): 5059 - 5066.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
R. van Boxtel, P. W. Toonen, H. S. van Roekel, M. Verheul, B. M. G. Smits, J. Korving, A. de Bruin, and E. Cuppen
Lack of DNA mismatch repair protein MSH6 in the rat results in hereditary non-polyposis colorectal cancer-like tumorigenesis
Carcinogenesis, June 1, 2008; 29(6): 1290 - 1297.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
J. Kenyon and S. L. Gerson
The role of DNA damage repair in aging of adult stem cells
Nucleic Acids Res., December 26, 2007; (2007) gkm1064v1.
[Abstract] [Full Text] [PDF]


Home page
J. Med. Genet.Home page
J Barwell, L Pangon, S Hodgson, A Georgiou, I Kesterton, T Slade, M Taylor, S J Payne, H Brinkman, J Smythe, et al.
Biallelic mutation of MSH2 in primary human cells is associated with sensitivity to irradiation and altered RAD51 foci kinetics
J. Med. Genet., August 1, 2007; 44(8): 516 - 520.
[Abstract] [Full Text] [PDF]


Home page
J. Med. Genet.Home page
R. H Scott, T. Homfray, N. L Huxter, S. G Mitton, R. Nash, M. N Potter, D. Lancaster, and N. Rahman
Familial T-cell non-Hodgkin lymphoma caused by biallelic MSH2 mutations
J. Med. Genet., July 1, 2007; 44(7): e83 - e83.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
S. Peron, Q. Pan-Hammarstrom, K. Imai, L. Du, N. Taubenheim, O. Sanal, L. Marodi, A. Bergelin-Besancon, M. Benkerrou, J.-P. de Villartay, et al.
A primary immunodeficiency characterized by defective immunoglobulin class switch recombination and impaired DNA repair
J. Exp. Med., May 14, 2007; 204(5): 1207 - 1216.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
N. Rahman and R. H. Scott
Cancer genes associated with phenotypes in monoallelic and biallelic mutation carriers: new lessons from old players
Hum. Mol. Genet., April 15, 2007; 16(R1): R60 - R66.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
E. C. Chao and S. M. Lipkin
Molecular models for the tissue specificity of DNA mismatch repair-deficient carcinogenesis
Nucleic Acids Res., February 6, 2006; 34(3): 840 - 852.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
S. Gill, N. M. Lindor, L. J. Burgart, R. Smalley, O. Leontovich, A. J. French, R. M. Goldberg, D. J. Sargent, J. R. Jass, J. L. Hopper, et al.
Isolated Loss of PMS2 Expression in Colorectal Cancers: Frequency, Patient Age, and Familial Aggregation
Clin. Cancer Res., September 15, 2005; 11(18): 6466 - 6471.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
M. R. Hegde, B. Chong, M. E. Blazo, L. H. E. Chin, P. A. Ward, M. M. Chintagumpala, J. Y. Kim, S. E. Plon, and C. S. Richards
A Homozygous Mutation in MSH6 Causes Turcot Syndrome
Clin. Cancer Res., July 1, 2005; 11(13): 4689 - 4693.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
J. Offman, K. Gascoigne, F. Bristow, P. Macpherson, M. Bignami, I. Casorelli, G. Leone, L. Pagano, S. Sica, O. Halil, et al.
Repeated Sequences in CASPASE-5 and FANCD2 but not NF1 Are Targets for Mutation in Microsatellite-Unstable Acute Leukemia/Myelodysplastic Syndrome
Mol. Cancer Res., May 1, 2005; 3(5): 251 - 260.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. R. Campbell, P. N. Nation, and S. E. Andrew
A Lack of DNA Mismatch Repair on an Athymic Murine Background Predisposes to Hematologic Malignancy
Cancer Res., April 1, 2005; 65(7): 2626 - 2635.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
M. R. Velangi, E. C. Matheson, G. J. Morgan, G. H. Jackson, P. R. Taylor, A. G. Hall, and J. A.E. Irving
DNA mismatch repair pathway defects in the pathogenesis and evolution of myeloma
Carcinogenesis, October 1, 2004; 25(10): 1795 - 1803.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
L. C. Young, K. J. Thulien, M. R. Campbell, V. A. Tron, and S. E. Andrew
DNA mismatch repair proteins promote apoptosis and suppress tumorigenesis in response to UVB irradiation: an in vivo study
Carcinogenesis, October 1, 2004; 25(10): 1821 - 1827.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
K. E. Nichols, J. A. Heath, D. Friedman, J. A. Biegel, A. Ganguly, P. Mauch, and L. Diller
TP53, BRCA1, and BRCA2 Tumor Suppressor Genes Are Not Commonly Mutated in Survivors of Hodgkin's Disease With Second Primary Neoplasms
J. Clin. Oncol., December 15, 2003; 21(24): 4505 - 4509.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. S. Reese, L. Liu, and S. L. Gerson
Repopulating defect of mismatch repair-deficient hematopoietic stem cells
Blood, September 1, 2003; 102(5): 1626 - 1633.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2002 by the American Association for Cancer Research.